Cipla Quality Chemical Industries Limited has a state-of-the-art pharmaceutical manufacturing plant located in Kampala, Uganda primarily manufacturing antiretroviral drugs (ARVs) and artemisinin-based combination therapies (ACTs) to combat HIV/AIDS and Malaria respectively.

The company was founded in June 2005 as a joint venture between Quality Chemicals Limited (QCL), a private limited company incorporated in Uganda for the importation and distribution of pharmaceutical drugs, and Cipla Ltd, a leading Indian pharmaceutical company. The joint venture then attracted Capitalworks and TLG Capital Investment each with a vision to have Cipla Quality Chemical Industries Limited a center of pharmaceutical manufacturing excellence in the region.

CiplaQCIL is designed to meet the world’s most stringent pharmaceutical regulatory standards and is pre-qualified by the World Health Organization (WHO) as an additional contract manufacturing site for Cipla Ltd’s products.

Manufacturing

Pharmaceutical

Cipla Quality Chemical Industries Ltd

Cipla Quality Chemical Industries Ltd

Org chart

Similar companies